Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Leading Ibogaine Drug Treatment Doctor Carlos Silva Joins Ibogaine University
  • USA - English


News provided by

Ibogaine University Medical Center

May 08, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Carlos Silva
Dr. Carlos Silva

(PRWEB) May 08, 2014 -- Ibogaine University is pleased to welcome Dr. Carlos Silva to join in the purpose of helping individuals conquer addiction without experiencing withdrawal, and to do so safely, in a comfortable environment.

You prevent the patient from going into physical withdrawals, and also you prevent the patient from actually getting the cravings to continue using again. It kind of resets the brain's chemistry.

Post this

Because it has the distinction of being fully licensed and equipped, Ibogaine University is unique among centers that offer Ibogaine treatment. Patients can receive treatment and medical care on site, eliminating the need for outside emergency assistance as well as unnecessary time spent waiting on doctors. The treatment center offers a peaceful beachfront location, comfortable rooms with medical staff close at hand, a nearby spa to aid in relaxation, counseling, and an assortment of activities that encourage healthy life habits.

With his arrival, the leading Ibogaine drug treatment doctor joins Ibogaine University and brings with him a wealth of successful experience. Dr. Carlos Silva graduated from the School of Medicine at the University of Baja California and went on to specialize in internal medicine at Tijuana General Hospital. For the past three years, he has served at Rosarito General Hospital in the position of Chief of Internal Medicine. His passion for helping patients break free from addictions has led to four years specializing in Ibogaine treatment. Dr. Silva has treated over six hundred patients; none of which suffered negative health effects, and is eager to continue treating individuals suffering from serious drug addictions.

As chief medical doctor at Ibogaine University, Dr. Carlos Silva is in charge of patients' everyday treatment. He carries with him valuable experience from working at several notable Ibogaine treatment centers, but chose to become part of Ibogaine University because it allows him to meet his high standards for patient care and treatment. Safety is the top priority for Dr. Silva and Ibogaine University, and is achieved by means of careful screening and meticulous patient care.

Despite Dr. Silva's extensive experience in treating patients with severe addictions to such substances as heroin, cocaine, alcohol, methamphetamine, and prescription pills, he has never in the hundreds of patients who have undergone Ibogaine treatment encountered health-related issues or a patient's death. His positive results are the result of his strong concern for safety and a thorough screening process to ensure that Ibogaine treatment is the right choice for each patient.

Dr. Silva chose to join Ibogaine University for its outstanding patient care and staff as well as its commitment to safety. Every stage in the treatment process is tailored for the safety and well being of patients. First, treatment coordinators perform the Ibogaine University’s pre-screening procedure prior to the patient’s arrival at the clinic. Further screening, including basic blood tests and an EKG/ECG, is then performed before treatment can begin; in this time, the patient can obtain a psychologist's evaluation and guidance from counselors in focusing on goals and intentions in undergoing treatment.

While the process consists of a stay of seven days, the patient receives the first test dose on the second day, following labs. The test dosage effects are carefully evaluated and adjusted if necessary. After the proper dose is determined, Ibogaine HCL is administered in a flood dose, which leads to a state of deep introspection and emotional processing. Because it also typically results in a temporary state of physical weakness and exhaustion, Ibogaine University's staff is especially attentive to the patient's needs in this time.

The biggest advantage that Ibogaine treatment offers is the cessation of the addictive substance without the trauma of withdrawal symptoms, which can last for three weeks that feel like an eternity. Dr. Silva and Ibogaine University are passionate in curing patients of addictions without the negative side effects that quitting abruptly entails. The only negative effects during the first few days of treatment are physical and mental weariness, which is why comfort and relaxation are emphasized in the week-long stay at the clinic.

Dr. Carlos Silva and Ibogaine University continue to pursue the well being of addicted individuals with the highest standards of safety, comfort, and care.

Dr. Silva was recently interviewed by Milwaukee NBC Channel 4 news regarding his approach to Ibogaine Treatment here.

About Ibogaine University:
Ibogaine University is the premiere institution for Ibogaine treatment for both drug addiction and mental and spiritual growth. Ibogaine University is one of very few clinics in North America which is licensed to both do Ibogaine treatment and offer professional medical and psychiatric services. By coming to Ibogaine University, you are receiving Ibogaine treatment from some of the most knowledgeable Ibogaine treatment providers in the world. As well, you are joining a community where information and communication between patients, doctors, and counselors is unparalleled. By being admitted to the Ibogaine University, you are making a commitment to give yourself the best possible opportunity to become the best possible person you can be. Learn to live again!

Charles Johnston, Ibogaine University Medical Center, http://www.ibogaineuniversity.com, +1 8003519777, charles@ibogaineuniversity.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.